Rep. Thomas H. Kean, Jr. sells $15K–$50K of Johnson & Johnson (JNJ) while on a related committee
Rep. Thomas H. Kean, Jr. (R-NJ) reported a sale of JNJ worth $15K–$50K.
Rep. Thomas H. Kean, Jr. (R-NJ) reported that they sold part of a holding in Johnson & Johnson (JNJ) stock worth $15K–$50K on November 20, 2025. The trade was disclosed in a Periodic Transaction Report filed on December 19, 2025, 29 days after the trade.
Jr. sits on the House Committee on Energy and Commerce, whose work touches health care, an area that matters to Johnson & Johnson.
In the year before, Jr. reported 1 other trade in JNJ: 0 purchases and 1 sale.
Across all their reports we have read, Thomas H. Kean, Jr. disclosed 113 stock trades.
The law gives only a range for each trade, so the exact amount and price are not public.
What happened next: since the week of the sale, JNJ has risen 38.4%. A fall after a sale means the sale came before a drop.
Source: Periodic Transaction Report ↗. Written automatically from the report and weekly price data. Information, not investment advice. Published free for the public; congressional disclosure reports may not be used for commercial purposes or soliciting money.
Examples
In 2020 several senators faced questions over stock sales made after private briefings on the coronavirus. Those trades became public through the same kind of report this story is built from.
Explain it like I'm 13
Members of Congress write the rules for many companies, so the law makes them tell the public when they buy or sell stocks. This report is like a referee saying which team's merchandise they bought: it does not mean they did anything wrong, but it lets everyone check.